Page 316 - Read Online

Page 8 of 10 Ramadori. Hepatoma Res 2020;6:28 I http://dx.doi.org/10.20517/2394-5079.2020.43

DECLARATIONS
Authors’ contributions
The author contributed solely to the article.

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
The author declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2020.

REFERENCES
1. Wang Y, Li X, Liu W, Gan M, Zhang L, et al. Discovery of a subgenotype of human coronavirus NL63 associated with severe lower
respiratory tract infection in China, 2018. Emerg Microbes Infect 2020;9:246-55.
2. Zhou F, Yu T, Du R, Fan G, Liu Y, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan,
China: a retrospective cohort study. Lancet 2020;395:1054-62.
3. Huang C, Wang Y, Li X, Ren L, Zhao J, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet
2020;395:497-506.
4. Shi H, Han X, Jiang N, Cao Y, Alwalid O, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a
descriptive study. Lancet Infect Dis 2020;20:425-34.
5. Chen T, Wu D, Chen H, Yan W, Yang D, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019:
retrospective study. BMJ 2020;368:m1091.
6. Wang D, Hu B, Hu C, Zhu F, Liu X, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected
Pneumonia in Wuhan, China. JAMA 2020;323:1061-9.
7. Zhu N, Zhang D, Wang W, Li X, Yang B, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med
2020;382:727-33.
8. Li Q, Guan X, Wu P, Wang X, Zhou L, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N
Engl J Med 2020;382:1199-1207.
9. Liu Y, Yang Y, Zhang C, Huang F, Wang F, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads
and lung injury. Sci China Life Sci 2020;63:364-74.
10. Zhang Y, Xiao M, Zhang S, Xia P, Cao W, et al. Coagulopathy and antiphosphlipid antibodies in Patients with COVID-19. N Engl J Med
2020;382:e38.
11. Liu CL, Lu YT, Peng MJ, Chen PJ, Lin RL, et al. Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of
fever. Chest 2004;126:509-17.
12. Leong HN, Earnest A, Lim HH, Chin CF, Tan C, et al. SARS in Singapore--predictors of disease severity. Ann Acad Med Singapore
2006;35:326-31.
13. Ko JH, Park GE, Lee JY, Lee JY, Cho SY, et al. Predictive factors for pneumonia development and progression to respiratory failure in
MERS-CoV infected patients. J Infection 2016;73:468-75.
14. Leem AY, Park B, Kim YS, Jung JY, Won S. Incidence and risk of chronic obstructive pulmonary disease in a Korean community-based
cohort. Int J Chron Obstruct Pulmon Dis 2018;13:509-17.
15. Zhang J, Wang X, Jia X, Li J, Hu K, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in
Wuhan, China. Clin Microbiol Infect 2020; Epub ahead of print. doi: 10.1016/j.cmi.2020.04.012.
16. Gong J, Ou J, Qiu X, Jie Y, Chen Y, et al. A tool to early predict severe corona virus disease 2019 (COVID-19) : a multicenter study using